In chemotherapy-induced organ toxicity mitigation
Scholar“Research focused on Chemotherapy-induced organ toxicity mitigation and adjacent fields.”
8
H-index
273
Citations
Nahed has not officially claimed their profile. If you are Nahed, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
ahed A. Raslan is a researcher working on Chemotherapy-induced organ toxicity mitigation. A fuller summary will appear once they update their profile.
Nahed's work has been cited 273 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
Research themes (UN SDGs)
Frontiers in Pharmacology, Chemotherapy-induced organ toxicity mitigation
Naunyn-Schmiedeberg s Archives of Pharmacology, Pharmacological Effects of Medicinal Plants
Naunyn-Schmiedeberg s Archives of Pharmacology, Drug-Induced Hepatotoxicity and Protection
Naunyn-Schmiedeberg s Archives of Pharmacology, Chemotherapy-induced organ toxicity mitigation
Naunyn-Schmiedeberg s Archives of Pharmacology, Wnt/β-catenin signaling in development and cancer
Naunyn-Schmiedeberg s Archives of Pharmacology, Chemotherapy-induced organ toxicity mitigation
Molecules, Metabolism, Diabetes, and Cancer
Toxics, Chemotherapy-induced cardiotoxicity and mitigation
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Free to claim · takes a minute to verify it’s you
